Abiopharma

News list

FEDERATED HERMES, INC. (FHI)

SEC News
July 30, 2026, 21:03 UTC

(99% Positive) FEDERATED HERMES, INC. (FHI) Reports Q3 2026 Financial Results

Full text

News bot July 30, 2026, 9:04 p.m.

📋 FEDERATED HERMES, INC. (FHI) - Financial Results

Filing Date: 2026-07-30

Accepted: 2026-07-30 17:03:24

Event Type: Financial Results

Event Details:

FEDERATED HERMES, INC. (FHI) Reports the reporting period Financial Results FEDERATED HERMES, INC. (FHI) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: (1,730)
Net Income: 200696
EPS: $1.38
Cash and equivalents: $480,710

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2026	2025	Change ($)	Change (%)
Liabilities Redeemable Noncontrolling Interests And Equity Other Long Term Liabilities	330.00K	330.00K	$0.00	+0.00%
Revenue	502.78K	424.84K	$77.93K	+18.34%
Noncontrolling Interests	106.81K	96.69K	$10.12K	+10.47%
Intangible Assets, Net	1.50M	1.18M	$319.26K	+26.97%

💼 Business Developments:

Partnership: Not available
Acquisition
Licensing: Not available
Regulatory Approval: Not available
Executive Changes: Not available

Structured Data:

Company Name: FEDERATED HERMES, INC.
Ticker Symbol: FHI